Skip to main content
. 2022 Feb 28;47(3):419–429. doi: 10.1007/s13318-021-00745-6

Fig. 2.

Fig. 2

Median plasma concentration–time curves (semilog scale) for the abrocitinib parent drug in the presence and absence of fluvoxamine (a), fluconazole (b), rifampin (c), and probenecid (d); BID twice daily, QD once daily, SD single dose